Clinical Study

Neoadjuvant Chemotherapy in Locally Advanced and Borderline Resectable Nonsquamous Sinonasal Tumors (Esthesioneuroblastoma and Sinonasal Tumor with Neuroendocrine Differentiation)

Table 1

Baseline details according to histological subtypes.

VariableEsthesioneuroblastoma
( patients)
Sinonasal tumor with neuroendocrine differentiation ( patients)Total ( patients)

Median age40 years (IQR 36.5–42.75 years)45 years (IQR 36.5–57.0 years) 42 years (IQR 37–47 years)
Gender
 Male231119
 Female04 0206
ECOG PS
 PS 0-1121325
 PS 2 000000
Grade
 III-IV101308

All patients had high grade neuroendocrine tumors.